HCW Biologics Inc

NASDAQ HCWB

Download Data

HCW Biologics Inc Return on Total Capital (ROTC) for the year ending December 31, 2023: -125.51%

HCW Biologics Inc Return on Total Capital (ROTC) is -125.51% for the year ending December 31, 2023, a -328.38% change year over year. Return on total capital measures the profitability of a company relative to its total capital, which includes total debt and shareholders' equity. It is calculated by dividing the net income by the sum of total debt and shareholders' equity. This ratio provides insights into the return generated for each unit of total capital invested in the company. A higher return on total capital indicates better profitability and efficient utilization of both debt and equity capital.
  • HCW Biologics Inc Return on Total Capital (ROTC) for the year ending December 31, 2022 was -29.30%.
NASDAQ: HCWB

HCW Biologics Inc

CEO Dr. Hing C. Wong Ph.D.
IPO Date July 20, 2021
Location United States
Headquarters 2929 North Commerce Parkway, Miramar, FL, United States, 33025
Employees 45
Sector Healthcare
Industry Biotechnology
Description

HCW Biologics Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing novel immunotherapies for chronic, low-grade inflammation, and age-related diseases in the United States. The company's lead products include HCW9218, which is in Phase 1 clinical chemo-refractory/chemo-resistant solid tumors with pancreatic, ovarian, breast, prostate, and colorectal cancers, as well as Phase 2 clinical trial with metastatic advanced stage ovarian cancer patients; and HCW9302 for autoimmune and proinflammatory diseases, such as alopecia areata diseases. It also develops HCW9201, a cell-based therapy that is in Phase I clinical trials for the treatment of patients with relapsed/refractory acute myelogenous leukemia; and HCW9206, an injectable immunotherapeutic to use as adjuvant for adoptive cell therapy in cancer treatment. The company was incorporated in 2018 and is headquartered in Miramar, Florida.

Similar companies

ANEB

Anebulo Pharmaceuticals Inc

NA

NA

ELYM

Eliem Therapeutics Inc

NA

NA

MNOV

MediciNova Inc

NA

NA

CYT

Cyteir Therapeutics Inc

NA

NA

IPSC

Century Therapeutics Inc

NA

NA

StockViz Staff

September 20, 2024

Any question? Send us an email